UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 915

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease

Journal of the American Society of Nephrology, 2003-03, Vol.14 (3), p.575-583

2003

Volltextzugriff (PDF)

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism

Kidney international, 2003-01, Vol.63 (1), p.248-254

2003

Volltextzugriff (PDF)

Cinacalcet Hydrochloride Maintains Long-Term Normocalcemia in Patients with Primary Hyperparathyroidism

The journal of clinical endocrinology and metabolism, 2005-01, Vol.90 (1), p.135-141

2005

Volltextzugriff (PDF)

The Calcimimetic Cinacalcet Normalizes Serum Calcium in Subjects with Primary Hyperparathyroidism

The journal of clinical endocrinology and metabolism, 2003-12, Vol.88 (12), p.5644-5649

2003

Volltextzugriff (PDF)

Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl

Kidney international, 2005-02, Vol.67 (2), p.760-771

2005

Volltextzugriff (PDF)

Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism

Nephrology, dialysis, transplantation, 2008-07, Vol.23 (7), p.2311-2318

2008

Volltextzugriff (PDF)

The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism

Journal of the American Society of Nephrology, 2002-04, Vol.13 (4), p.1017-1024

2002

Volltextzugriff (PDF)

A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism

Kidney international, 2000-07, Vol.58 (1), p.436-445

2000

Volltextzugriff (PDF)

First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl

Kidney international, 2005-09, Vol.68 (3), p.1236-1243

2005

Volltextzugriff (PDF)

Among Patients Meeting the KDIGO CKD Practice Point Criterion for Treatment of Metabolic Acidosis, Higher Serum Bicarbonate Concentrations Are Associated with Slower CKD Progression: SA-PO496

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

P139 OLORINAB, A PERIPHERALLY RESTRICTED, HIGHLY SELECTIVE AGONIST OF THE CANNABINOID RECEPTOR TYPE 2 FOR THE MANAGEMENT OF VISCERAL PAIN IN INFLAMMATORY BOWEL DISEASE (IBD) – PRECLINICAL AND EARLY CLINICAL DEVELOPMENT

Gastroenterology (New York, N.Y. 1943), 2019-02, Vol.156 (3), p.S92-S93

2019

Volltextzugriff (PDF)

P139 OLORINAB, A PERIPHERALLY RESTRICTED, HIGHLY SELECTIVE AGONIST OF THE CANNABINOID RECEPTOR TYPE 2 FOR THE MANAGEMENT OF VISCERAL PAIN IN INFLAMMATORY BOWEL DISEASE (IBD) – PRECLINICAL AND EARLY CLINICAL DEVELOPMENT

Inflammatory bowel diseases, 2019-02, Vol.25 (Supplement_1), p.S64-S64

2019

Volltextzugriff (PDF)

Su1930 – Safety and Efficacy of Olorinab, a Peripherally Restricted, Highly Selective, Cannabinoid Receptor 2 Agonist in a Phase 2A Study in Chronic Abdominal Pain Associated with Crohn’s Disease

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-665-S-665

2019

Volltextzugriff (PDF)

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

The New England journal of medicine, 2004-04, Vol.350 (15), p.1516-1525

2004

Volltextzugriff (PDF)

Reply

Nephrology, dialysis, transplantation, 2008-10, Vol.23 (10), p.3371

2008

Volltextzugriff (PDF)

Reply

Nephrology, dialysis, transplantation, 2008-10, Vol.23 (10), p.3371-3372

2008

Volltextzugriff (PDF)

Reply

Nephrology, dialysis, transplantation, 2008-10, Vol.23 (10), p.3371-3372

2008

Volltextzugriff (PDF)

A Randomized Phase 3 Study of Peripheral Blood Progenitor Cell Mobilization With Stem Cell Factor and Filgrastim in High-Risk Breast Cancer Patients

Blood, 1999-04, Vol.93 (8), p.2491-2501

1999

Volltextzugriff (PDF)

Future role of calcimimetics in end-stage renal disease

Advances in renal replacement therapy, 2002-07, Vol.9 (3), p.200-208

2002

Volltextzugriff (PDF)

TECHNICAL NOTE: Achieving NKF-K-DOQI registered bone metabolism and disease treatment goals with cinacalcet HCl

Kidney international, 2005-02, Vol.67 (2), p.760-771

2005

Volltextzugriff (PDF)

Relative Roles of Source Composition, Fractional Crystallization and Crustal Contamination in the Petrogenesis of Andean Volcanic Rocks [and Discussion]

Philosophical transactions of the Royal Society of London. Series A: Mathematical and physical sciences, 1984-04, Vol.310 (1514), p.675-692

1984

Volltextzugriff (PDF)

Population-based resequencing of experimentally evolved populations reveals the genetic basis of body size variation in Drosophila melanogaster

PLoS genetics, 2011-03, Vol.7 (3), p.e1001336-e1001336

2011

Volltextzugriff (PDF)

Meiotic DNA double-strand breaks and chromosome asynapsis in mice are monitored by distinct HORMAD2-independent and -dependent mechanisms

Genes & development, 2012-05, Vol.26 (9), p.958-973

2012

Volltextzugriff (PDF)

Reliability, factorial validity, and interrelationships of five commonly used change of direction speed tests

Scandinavian journal of medicine & science in sports, 2014-06, Vol.24 (3), p.500-506

2014

Volltextzugriff (PDF)

DNA methylation across the genome in aged human skeletal muscle tissue and muscle-derived cells: the role of HOX genes and physical activity

Scientific reports, 2020-09, Vol.10 (1), p.15360, Article 15360

2020

Volltextzugriff (PDF)

1 – 25 von 915

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(790)
Mit Volltextzugriff
(725)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(912)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Structural Geology
(28)
Blood
(14)
Nature
(14)
Biology Of Blood And Marrow Transplantation
(12)
Heart, Lung & Circulation
(10)
Kidney International
(9)
Bmj Open
(8)
Clinical Cancer Research
(8)
Journal Of Clinical Oncology
(8)
Bone Marrow Transplantation
(7)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism

Cinacalcet Hydrochloride Maintains Long-Term Normocalcemia in Patients with Primary Hyperparathyroidism

The Calcimimetic Cinacalcet Normalizes Serum Calcium in Subjects with Primary Hyperparathyroidism

Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl

Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism

The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism

A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism

First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl

Among Patients Meeting the KDIGO CKD Practice Point Criterion for Treatment of Metabolic Acidosis, Higher Serum Bicarbonate Concentrations Are Associated with Slower CKD Progression: SA-PO496

P139 OLORINAB, A PERIPHERALLY RESTRICTED, HIGHLY SELECTIVE AGONIST OF THE CANNABINOID RECEPTOR TYPE 2 FOR THE MANAGEMENT OF VISCERAL PAIN IN INFLAMMATORY BOWEL DISEASE (IBD) – PRECLINICAL AND EARLY CLINICAL DEVELOPMENT

P139 OLORINAB, A PERIPHERALLY RESTRICTED, HIGHLY SELECTIVE AGONIST OF THE CANNABINOID RECEPTOR TYPE 2 FOR THE MANAGEMENT OF VISCERAL PAIN IN INFLAMMATORY BOWEL DISEASE (IBD) – PRECLINICAL AND EARLY CLINICAL DEVELOPMENT

Su1930 – Safety and Efficacy of Olorinab, a Peripherally Restricted, Highly Selective, Cannabinoid Receptor 2 Agonist in a Phase 2A Study in Chronic Abdominal Pain Associated with Crohn’s Disease

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Reply

Reply

Reply

A Randomized Phase 3 Study of Peripheral Blood Progenitor Cell Mobilization With Stem Cell Factor and Filgrastim in High-Risk Breast Cancer Patients

Future role of calcimimetics in end-stage renal disease

TECHNICAL NOTE: Achieving NKF-K-DOQI registered bone metabolism and disease treatment goals with cinacalcet HCl

Relative Roles of Source Composition, Fractional Crystallization and Crustal Contamination in the Petrogenesis of Andean Volcanic Rocks [and Discussion]

Population-based resequencing of experimentally evolved populations reveals the genetic basis of body size variation in Drosophila melanogaster

Meiotic DNA double-strand breaks and chromosome asynapsis in mice are monitored by distinct HORMAD2-independent and -dependent mechanisms

Reliability, factorial validity, and interrelationships of five commonly used change of direction speed tests

DNA methylation across the genome in aged human skeletal muscle tissue and muscle-derived cells: the role of HOX genes and physical activity

Suchergebnisse filtern